Additionally, the percentage of CD163+EPOR+ TAMs had a positive linear association with malignant phenotypes including the number of lung metastases, the maximal diameter of lung metastases, and pathologic grade, as well as poor disease-free survival (DFS) and overall survival (OS), especially among patients with anemia. This evidence concerns the gene CD163 and anemia.